In addition to in-depth coverage of FDA's notice of a public hearing to consider a "new paradigm" for OTC pharmaceutical access, this week's issue of "The Tan Sheet" features stories on an upcoming FDA advisory committee meeting to discuss OTC home-use anthrax MedKits and an electronic cigarette company that aims to make harm-reduction/nicotine-replacement therapy claims.
"The Tan Sheet" also looks at a federal court's ruling that went in favor of supplement firm Garden of Life and against the Federal Trade Commission. We've got updates on Abbott, Colgate-Palmolive and Procter & Gamble, too.
For much more, and "The Tan Sheet's" full March 5 table of contents, click here.
"The Tan Sheet" is your source for the most comprehensive and in-depth coverage of the OTC drug and nutritional industries. Start your free trial subscription here -- no credit card required.
Also, follow "The Tan Sheet" on Twitter and Facebook.
- Dan Schiff (d.schiff@elsevier.com)
